333 related articles for article (PubMed ID: 16492804)
1. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
[TBL] [Abstract][Full Text] [Related]
2. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire.
Silver K; Ferry H; Crockford T; Cornall RJ
Eur J Immunol; 2006 Jun; 36(6):1404-12. PubMed ID: 16703567
[TBL] [Abstract][Full Text] [Related]
3. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
[TBL] [Abstract][Full Text] [Related]
4. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
5. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
8. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
9. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
10. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
11. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
[TBL] [Abstract][Full Text] [Related]
12. B cell-intrinsic TLR9 expression is protective in murine lupus.
Tilstra JS; John S; Gordon RA; Leibler C; Kashgarian M; Bastacky S; Nickerson KM; Shlomchik MJ
J Clin Invest; 2020 Jun; 130(6):3172-3187. PubMed ID: 32191633
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
14. Immunology. Discriminating microbe from self suffers a double toll.
Goodnow CC
Science; 2006 Jun; 312(5780):1606-8. PubMed ID: 16778043
[No Abstract] [Full Text] [Related]
15. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
[TBL] [Abstract][Full Text] [Related]
16. CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88.
Lin L; Gerth AJ; Peng SL
Eur J Immunol; 2004 May; 34(5):1483-7. PubMed ID: 15114682
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
[TBL] [Abstract][Full Text] [Related]
18. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
Li X; Egorina E; Bertelsen EL; Dahlen H; Hannestad K
Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML; Baudino L; Izui S
J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
[TBL] [Abstract][Full Text] [Related]
20. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
